Powered by

Jonsson Comprehensive Cancer Center: Antibody Eradicates Leukemia Stem Cells

Oct 16, 2019 - Targeted News Service

The Jonsson Comprehensive Cancer Center at the University of California at Los Angeles issued the following news:

* * *

- UCLA researchers develop an antibody that could keep one form of the disease from persisting after treatment

* * *

The introduction of the drug imatinib in 2001 revolutionized the treatment of a type of cancer called chronic myelogenous leukemia. In more than 80% of people with CML who received the drug, the disease went into complete remission.